The controversial head of the U.S. Food and Drug Administration's vaccines and biologics unit, Dr. Vinay Prasad, will leave the agency at the end of April. FDA commissioner Dr. Marty Makary posted ...
FDA Commissioner Marty Makary announced the news to FDA staff in an email late Friday, saying Vinay Prasad would depart at ...
Center for Biologics Evaluation and Research Director Vinay Prasad will exit the FDA for the second time after a controversial run that saw the oncologist butt heads with colleagues and ruffle ...
4D Molecular Therapeutics, Inc. ( FDMT) TD Cowen 46th Annual Health Care Conference March 3, 2026 10:30 AM EST ...
A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...
Regenxbio (RGNX) hit by FDA CRL for RGX-121; valuation discount, cash runway to 2027, risks vs RGX-202 upside. Click here to ...
China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...
UniQure needs to run another trial to prove its gene therapy "actually helps people with Huntington's disease," said a senior FDA official.
Subjecting participants to invasive procedures without the prospect of therapeutic benefit is unjustifiable,” says the CEO of ...
Even in mice with existing amyloid plaques, one injection of the gene therapy was associated with a roughly 50 percent ...
Gregory and Tara Scott are camping outside a new Buckhead store, hoping to raise money for gene therapy research for their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results